Impact of metabolic syndrome on functional outcomes and complications of surgical treatment of prostate cancer.

Alessandro MorlaccoFabrizio Dal MoroLaureano J RangelRachel E CarlsonMatteo SoligoRobert Jeffrey Karnes

Published in: Journal of surgical oncology (2019)

In the present study RP was safe from the complications standpoint in MetS patients, but the presence of the syndrome was a significant risk factor for post-RP incontinence and impotence.

Keyphrases

prostate cancer
metabolic syndrome
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
radical prostatectomy
peritoneal dialysis
cardiovascular disease
type diabetes
patient reported outcomes
uric acid